Daily Stock Opinions and Ratings

Opinions

Michael SprungBioscriptBYT.TODON'T BUYDec 08, 2006

Market has indicated this company is in trouble. Negative earnings and he doesn’t see any prospect for that to turn around.

Michael Sprung

Unlock Rating

$0.55

Stock price when the opinion was issued

misc industrial products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Doesn't follow it very closely. Thinks, that maybe it's failing.

DON'T BUY

Ranks 631 in the database which is in the bottom 15%. Expected to lose $0.03 in 2007 compared to $0.07 in 2006. Earnings growth is modest at 5%.

DON'T BUY

Not successful in finding good investment opportunities in this sector. Wants sustainable competitive advantage, good valuations and good technicals. This one’s valuations have dropped enough that he will be taking a look at it.

DON'T BUY

Involved in the security sector. Performed much better some time ago. Some of the small caps are having a bit of trouble. They need to show more contracts. Earnings tend to be a little on the spotty side.

DON'T BUY

Ranks 594, bottom 10/15% of the database. Earnings estimates have been shaved by 6%. Expected to lose$.07 in 06 and $.09 in 07.

DON'T BUY

This company is involved in high security. It is in the bottom 1-2% of the database. He has doubts. It is interesting technology but there are better places to be.

DON'T BUY

In the bottom 10% of his database. Earnings have been shaved by 5% in the last 90 days.Year over year earnings growth is down 22%. They are forecasted to lose $.09 in '05.

DON'T BUY

Have had some pretty good sales numbers. Analysts have chopped estimates by 41%. Ranks 619 out of 700 in the database.

DON'T BUY

Expected to lose $0.05 in Dec'04 and $0.03 in '05. Trades at 160 X PE. Too expensive.

BUY ON WEAKNESS

It bounces up and down based on contract announcements. Treat as a trading vehicle. A pretty good company.

WEAK BUY

Likes the technology, management and balance sheet. Have some good customers and getting good penetration. A little early to get real excited as to where it can go.

BUY ON WEAKNESS

Likes their technology. Good management stability. Have key brand name clients that are starting to sign up. Could drop another 20/30%.

BUY

Likes their technology. Have very high profile customers like Bloomberg and the Bank of China. Had a tough year last year. Could do well going forward.

BUY

Their deal with the Bank of China is significant. Have also signed Bloomberg Partnership as a partner. Huge endorsement.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Michael SprungBioscriptBYT.TODON'T BUYDec 08, 2006

You might be interested:

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Bioscript(BYT.TO)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Jim Cramer - Mad Money

Richard Orrell

Stockchase Insights

The Panic-Proof Portfolio (Stockchase Research)

Stan Wong